Search

Your search keyword '"M. V. Manikandan"' showing total 10 results
Start Over Author "M. V. Manikandan"
10 results on '"M. V. Manikandan"'

3. Is FAST FORWARD the Way Forward in Radiotherapy for Locally Advanced Breast Cancer – Learnings From the COVID Pandemic

Author

Giridhar, Prashanth, primary, Pradhan, Satyajit, additional, Pujari, Lincoln, additional, Singh, Prarabdh, additional, Shinghal, Abhishek, additional, Khandelwal, Chaturbhaj, additional, Mukherjee, Chandrima, additional, Tripathi, Mayank, additional, Shukla, Varun, additional, M. V., Manikandan, additional, Choudary, Zacchariah, additional, and Gupta, Anuj, additional

Published
2023
Full Text
View/download PDF

7. 18F-FDG PET/CT in Treatment Response Evaluation: Gastroesophageal Cancer

Author

M. V. Manikandan, Nilendu Purandare, Sneha Shah, Ameya D Puranik, Archi Agrawal, and Venkatesh Rangarajan

Subjects
Chemotherapy, PET-CT, Treatment response, medicine.medical_specialty, business.industry, medicine.medical_treatment, Mortality rate, Disease, Esophageal cancer, medicine.disease, Gastroesophageal cancer, medicine, Fdg pet ct, Radiology, business
Abstract

Esophageal cancer has a high mortality rate, and surgery is the mainstay of treatment for the locoregional disease. However, approximately 20–30% of patients with locally advanced disease have distant metastatic disease at presentation. In general, combined chemo-radiotherapy and neoadjuvant chemotherapy before surgery are some of the approaches used to improve local control. 18F-FDG PET/CT is the modality of choice to identify treatment responders from nonresponders. FDG PET/CT can distinguish viable from the nonviable disease. Still, false positives do occur because of posttreatment inflammatory changes due to the uptake of FDG in macrophages and activated leukocytes. We present multiple case scenarios of FDG PET/CT in response assessment of esophageal and gastric malignancy.

Published
2021
Full Text
View/download PDF

8. PET CT in Non-Hodgkin Lymphoma

Author

Venkatesh Rangarajan, M. V. Manikandan, Archi Agrawal, and Abhishek Uppal

Subjects
PET-CT, medicine.medical_specialty, business.industry, medicine.disease, Lymphoma, carbohydrates (lipids), Response assessment, immune system diseases, hemic and lymphatic diseases, Medicine, Hodgkin lymphoma, Fdg pet ct, Radiology, business, neoplasms
Abstract

18F-FDG PET CT has changed the way we look at Non-Hodgkin Lymphoma (NHL). FDG PET CT is used for staging and response assessment in NHL. In this chapter we discuss the role of PET CT in assessing NHL.

Published
2021
Full Text
View/download PDF

9. Renal granulomas mimicking as malignant renal masses on F18 FDG PET/CT in a case of urothelial carcinoma

Author

Santosh Menon, Venkatesh Rangarajan, Sneha Shah, Gagan Prakash, Nilendu Purandare, Ganesh Bakshi, M. V. Manikandan, Archi Agrawal, and Ameya D Puranik

Subjects
medicine.medical_specialty, Granuloma, business.industry, Carcinoma, General Medicine, Kidney Neoplasms, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Positron-Emission Tomography, medicine, Humans, Radiology, Nuclear Medicine and imaging, Fdg pet ct, Radiology, Radiopharmaceuticals, business, Carcinoma, Renal Cell, Urothelial carcinoma
Published
2020

10. 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Postsurgical and Postprocedural Setting in Thorax and Abdominopelvic Malignancies: A Pictorial Essay (Part II).

Author

Agrawal, Archi, Prakash, Anjali, Choudhury, Sayak, M. V., Manikandan, Jain, Yash, Purandare, Nilendu, Puranik, Ameya, Shah, Sneha, and Rangarajan, Venkatesh

Subjects
POSITRON emission tomography computed tomography, COMPUTED tomography, POSTOPERATIVE period
Abstract

This pictorial essay depicts normal appearances, complications and residual or recurrent disease on fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) studies in the postsurgical and postprocedural setting, other than head and neck malignancy. Reading and reporting FDG PET/CT in this scenario is daunting due to the multiple confounding false positives seen during this period. This article which is the second part in this series will familiarize the readers with the normal appearance and pitfalls seen in FDG PET/CT studies in thoracic and abdominopelvic malignancies during the postoperative and postprocedural period so as to avoid misinterpretations. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results